Integrated Report

Overview

The report records Pharmaniaga's strong 2021 growth, including a 77% revenue increase to RM4.8 billion driven particularly by COVID-19 vaccine activities. It reports a 15% reduction in GHG emissions against the 2019 baseline, alongside lower total energy consumption. The Group also recorded zero workplace fatalities across all operations.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services